XENOTHERA announces its participation in the American Society of Clinical Oncology (ASCO) congress, where the world's cancer experts gather each year to share the latest clinical trial data and innovations
Novel technology offers more durable valves based on genetic engineering preventing expression of foreign sugars, thereby minimizing structural valve deterioration due to calcification.
An international study led by a researcher from Tel Aviv University offers a novel technology that can assist many patients implanted with bioprosthetic heart valve by avoiding additional complicated replacement surgery.
TAU-Led Research Offers Novel Technology to Prevent Repeat Replacements of Faulty Heart Valves | The Jewish Press - JewishPress com | Jewish Press News Desk | 29 Adar I 5782 – March 1, 2022 jewishpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishpress.com Daily Mail and Mail on Sunday newspapers.